DrugPatentWatch Database Preview
Gemini Labs Llc Company Profile
» See Plans and Pricing
What is the competitive landscape for GEMINI LABS LLC, and what generic and branded alternatives to GEMINI LABS LLC drugs are available?
GEMINI LABS LLC has two approved drugs.
Drugs and US Patents for Gemini Labs Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gemini Labs Llc | OXANDRIN | oxandrolone | TABLET;ORAL | 013718-002 | Nov 5, 2001 | DISCN | Yes | No | Start Trial | Start Trial | |||||
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-003 | Dec 22, 1997 | DISCN | Yes | No | Start Trial | Start Trial | |||||
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-002 | Dec 22, 1997 | DISCN | Yes | No | Start Trial | Start Trial | |||||
Gemini Labs Llc | OXANDRIN | oxandrolone | TABLET;ORAL | 013718-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-001 | Dec 22, 1997 | DISCN | Yes | No | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Gemini Labs Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-003 | Dec 22, 1997 | 5,312,924 | Start Trial |
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-001 | Dec 22, 1997 | 6,143,769 | Start Trial |
Gemini Labs Llc | PRANDIN | repaglinide | TABLET;ORAL | 020741-002 | Dec 22, 1997 | 5,216,007 | Start Trial |
Gemini Labs Llc | OXANDRIN | oxandrolone | TABLET;ORAL | 013718-001 | Approved Prior to Jan 1, 1982 | 5,872,147 | Start Trial |
Gemini Labs Llc | OXANDRIN | oxandrolone | TABLET;ORAL | 013718-001 | Approved Prior to Jan 1, 1982 | 6,670,351 | Start Trial |
Gemini Labs Llc | OXANDRIN | oxandrolone | TABLET;ORAL | 013718-002 | Nov 5, 2001 | 6,670,351 | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for GEMINI LABS LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 0.5 mg, 1 mg and 2 mg | ➤ Subscribe | 2005-02-10 |
➤ Subscribe | Tablets | 2.5 mg and 10 mg | ➤ Subscribe | 2006-06-19 |
Similar Applicant Names
Here is a list of applicants with similar names.